Chang, Jei-Wen

Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation. [electronic resource] - Journal of cellular and molecular medicine Dec 2012 - 2935-49 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1582-4934

10.1111/j.1582-4934.2012.01610.x doi


Animals
Apoptosis
Ascorbic Acid--analogs & derivatives
CD4-Positive T-Lymphocytes--immunology
Cells, Cultured
Coculture Techniques
Creatinine--metabolism
Disease Progression
Epidermal Growth Factor--metabolism
Epithelial-Mesenchymal Transition
Female
Fibroblast Growth Factor 2--metabolism
Fibronectins--biosynthesis
Fibrosis
Glomerulosclerosis, Focal Segmental
Hepatocyte Growth Factor--metabolism
Humans
Kidney--cytology
Kidney Tubules, Proximal--cytology
Lymphocyte Count
Male
Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cells--metabolism
Microfilament Proteins--deficiency
Middle Aged
Nephrectomy
Podocytes--cytology
Rats
Rats, Sprague-Dawley
Renal Insufficiency, Chronic--metabolism
Transforming Growth Factor beta1--metabolism
Young Adult